TANG PRIZE / Drugs treating diabetes, obesity can do more: Tang Prize laureates

Svetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)